Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DALBAVANCIN vs DAPAGLIFLOZIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DALBAVANCIN vs DAPAGLIFLOZIN: Safety Overview

Metric DALBAVANCIN DAPAGLIFLOZIN
Total FAERS Reports 1,107 21,367
Deaths Reported 54 3,633
Death Rate 4.9% 17.0%
Hospitalizations 288 8,467
Average Patient Age 61.0 yrs 64.9 yrs
% Female Patients 46.7% 44.5%
FDA Approval Date May 23, 2014 Jan 8, 2014
Manufacturer Fresenius Kabi USA, LLC AstraZeneca Pharmaceuticals LP
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription